A randomised clinical trial to assess the adjuvant potential of methotrexate to corticosteroids in mucosal or limited mucocutaneous pemphigus vulgaris

Glucocorticoids are the mainstay of treatment for pemphigus vulgaris (PV). However, the requirement of high doses for long durations often leads to serious adverse events. Methotrexate as an adjuvant has shown potential in retrospective studies but randomized trials are lacking. The objective of the...

Descripción completa

Detalles Bibliográficos
Autores principales: Jain, Khimit, Thakur, Vishal, Handa, Sanjeev, Thakur, Neha, Shilpa, Sachdeva, Naresh, Mahajan, Rahul, De, Dipankar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9085868/
https://www.ncbi.nlm.nih.gov/pubmed/35534494
http://dx.doi.org/10.1038/s41598-022-11387-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9085868/
https://www.ncbi.nlm.nih.gov/pubmed/35534494
http://dx.doi.org/10.1038/s41598-022-11387-2

Ejemplares similares